ANIP
Ani Pharmaceuticals
$78.37
+$0.72 (+0.93%)Jul 27, 2026
Key metrics
The numbers that frame ANIP today
- Market cap
- $1.78B
- P/E (TTM)
- 19.3
- EV / FCF
- 10.9
- Gross margin
- 60.8%
- EV / Sales
- 2.3
- ROIC
- 14.3%
- Div yield
- 0%
- Debt / equity
- 1.1
- 52wk Low
- $62.61
- 52wk High
- $99.50
Growth
Revenue and earnings trend for ANIP
RevenueNet income
See the full growth breakdown
Revenue and earnings trends, margins and the multi-year trajectory - free with an account.
Create a free accountFree foreverNo card required
Already a member? Log inCash flow & returns
Free cash flow and financial health
Free cash flowNet debt
See the full cash-flow picture
Free cash flow detail, returns on capital and the balance-sheet trend - free with an account.
Create a free accountFree foreverNo card required
Already a member? Log inInsider trading
Recent insider buying and selling activity
PurchasesSales
Unlock every insider trade
See who is buying and selling, how much, and when - updated as new filings land.
Create a free accountFree foreverNo card required
Already a member? Log inFrequently asked questions
Plain-English answers about ANIP
Is Ani Pharmaceuticals a good buy?
Yes. Ani Pharmaceuticals has excellent quality and mixed momentum. Taken together, the setup leans positive. Growth looks weak, a caveat that does not overturn the setup. We think Ani Pharmaceuticals is selling at a low price.
What is the market capitalization of ANIP?
Ani Pharmaceuticals's market capitalization is $1.78B.
What is the P/E ratio for ANIP stock?
Ani Pharmaceuticals's current P/E ratio is 19.3.
What is the 52-week high for ANIP stock?
The 52-week high for Ani Pharmaceuticals is $99.50. The current close of $78.37 is 21.2% below that high.
What is the 52-week low for ANIP stock?
The 52-week low for Ani Pharmaceuticals is $62.61. The current close of $78.37 is 25.2% above that low.
Does ANIP stock pay dividends?
Ani Pharmaceuticals does not currently show a dividend per share in the company data.
What is the Debt / Equity ratio for ANIP?
Ani Pharmaceuticals's Debt / Equity ratio is 1.09.